Johann Aleith, Wendy Bergmann-Ewert, Brigitte Müller-Hilke
{"title":"Maximizing Insights, Minimizing Animal Testing: A Framework for Validating Multiparametric Single-Cell Cytokine Analysis Panels","authors":"Johann Aleith, Wendy Bergmann-Ewert, Brigitte Müller-Hilke","doi":"10.1002/eji.202451193","DOIUrl":null,"url":null,"abstract":"<p>Intracellular cytokine labeling combined with high-parametric flow cytometry offers substantial promise in elucidating the nuanced effector functions of cells. However, the establishment of complex multicolor panels is often laborious and the importance of validation processes may be underestimated in research practice. This raises the risk of prematurely translating multicolor panels into in vivo studies. Alternatively, researchers may resort to animal disease models to procure cytokine-producing cells. Both scenarios raise ethical concerns as they entail the potential for unnecessary animal suffering without yielding novel insights into immunobiology. Here, we perform multicolor panel optimization and validation without the need for stressful animal testing. We designed two spectral flow cytometry panels for cytokine expression analyses across mouse immune and joint cells. Animal testing was replaced by stimulated co-cultures of T cells, splenocytes, and fibroblast-like synoviocytes. These cultures were used for multicolor labeling experiments. Our method proved suitable for validating the two cytometry panels, as it provided a complex cellular environment in which a variety of cytokine-producing populations were identified. In summary, we here present a blueprint for the quality control of single-cell cytokine assays by cell culture and further introduce multicolor panels that can be employed for studies on inflammatory or infectious diseases.</p>","PeriodicalId":165,"journal":{"name":"European Journal of Immunology","volume":"55 3","pages":""},"PeriodicalIF":4.5000,"publicationDate":"2025-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/eji.202451193","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Immunology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/eji.202451193","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Intracellular cytokine labeling combined with high-parametric flow cytometry offers substantial promise in elucidating the nuanced effector functions of cells. However, the establishment of complex multicolor panels is often laborious and the importance of validation processes may be underestimated in research practice. This raises the risk of prematurely translating multicolor panels into in vivo studies. Alternatively, researchers may resort to animal disease models to procure cytokine-producing cells. Both scenarios raise ethical concerns as they entail the potential for unnecessary animal suffering without yielding novel insights into immunobiology. Here, we perform multicolor panel optimization and validation without the need for stressful animal testing. We designed two spectral flow cytometry panels for cytokine expression analyses across mouse immune and joint cells. Animal testing was replaced by stimulated co-cultures of T cells, splenocytes, and fibroblast-like synoviocytes. These cultures were used for multicolor labeling experiments. Our method proved suitable for validating the two cytometry panels, as it provided a complex cellular environment in which a variety of cytokine-producing populations were identified. In summary, we here present a blueprint for the quality control of single-cell cytokine assays by cell culture and further introduce multicolor panels that can be employed for studies on inflammatory or infectious diseases.
期刊介绍:
The European Journal of Immunology (EJI) is an official journal of EFIS. Established in 1971, EJI continues to serve the needs of the global immunology community covering basic, translational and clinical research, ranging from adaptive and innate immunity through to vaccines and immunotherapy, cancer, autoimmunity, allergy and more. Mechanistic insights and thought-provoking immunological findings are of interest, as are studies using the latest omics technologies. We offer fast track review for competitive situations, including recently scooped papers, format free submission, transparent and fair peer review and more as detailed in our policies.